This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai Senhui Medicine Co., Ltd., Shanghai Shengdi Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Cili Zhang - Innovator in Antibacterial Compounds
Introduction
Cili Zhang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial compounds. His work focuses on addressing the challenges posed by bacterial infections, especially those caused by Gram-negative bacteria.
Latest Patents
Cili Zhang holds a patent for a cephalosporin antibacterial compound and its preparation method. This innovative compound demonstrates antibacterial activity against various bacteria, providing a potential solution for treating infections that are difficult to manage with existing antibiotics. The patent highlights the importance of developing new antibacterial agents in the face of rising antibiotic resistance.
Career Highlights
Throughout his career, Cili Zhang has worked with prominent companies in the pharmaceutical industry. He has been associated with Shanghai Senhui Medicine Co., Ltd. and Shanghai Shengdi Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to contribute to the advancement of medical science and the development of effective treatments.
Collaborations
Cili Zhang has collaborated with several professionals in his field, including Jian Huang and Lingjian Zhu. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in antibacterial research.
Conclusion
Cili Zhang's contributions to the field of antibacterial compounds are noteworthy, as he continues to innovate and address critical health challenges. His patent and collaborations reflect his commitment to improving medical treatments and combating bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile